These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 14273321

  • 1. COMPARATIVE EFFECTS OF ISOPROTERENOL AEROSOLS ON AIRWAY RESISTANCE IN OBSTRUCTIVE PULMONARY DISEASES.
    COHEN AA, HALE FC.
    Am J Med Sci; 1965 Mar; 249():309-15. PubMed ID: 14273321
    [No Abstract] [Full Text] [Related]

  • 2. Comparison of isoproterenol and isoproterenol-phenylephrine aerosols.
    Grant JL, Werfelman N, Cook MR, Metherall W.
    Chest; 1971 Aug; 60(2):129-32. PubMed ID: 5571471
    [No Abstract] [Full Text] [Related]

  • 3. PULMONARY FUNCTION AND THERAPY IN DISABILITY APPLICANTS.
    SILVER HM.
    JAMA; 1965 Mar 29; 191():1059-63. PubMed ID: 14261886
    [No Abstract] [Full Text] [Related]

  • 4. VARIATION OF DRUG ACTION ON AIRWAY OBSTRUCTION IN MAN.
    ALTOUNYAN RE.
    Thorax; 1964 Sep 29; 19(5):406-15. PubMed ID: 14216969
    [No Abstract] [Full Text] [Related]

  • 5. Pulmonary resistance and maximal expiratory flowrate following isoprenaline in patients with chronic obstructive lung disease.
    Stănescu DC, Clément J, Van de Woestijne KP.
    Thorax; 1973 Nov 29; 28(6):716-20. PubMed ID: 4787983
    [Abstract] [Full Text] [Related]

  • 6. Bronchial component in chronic obstructive lung disease.
    Ayres SM, Griesbach SJ, Reimold F, Evans RG.
    Am J Med; 1974 Aug 29; 57(2):183-91. PubMed ID: 4843892
    [No Abstract] [Full Text] [Related]

  • 7. A comparison of the respiratory effects of SCH-13949W and isoproterenol aerosols in the treatment of patients with expiratory airflow disorders. Preliminary analysis in a long-term trial in ambulatory patients.
    Cohen BM.
    Postgrad Med J; 1971 Mar 29; 47():Suppl:63-71. PubMed ID: 4929396
    [No Abstract] [Full Text] [Related]

  • 8. A comparison of the action of salbutamol and of isoprenaline on airway resistance in 30 patients with obstructive airways disease.
    Sadoul P, Sentissi M.
    Postgrad Med J; 1971 Mar 29; 47():Suppl:111-2. PubMed ID: 5572508
    [No Abstract] [Full Text] [Related]

  • 9. Total pulmonary and airway resistances as measures of the relief of bronchospasm.
    Cohen BM.
    Int Surg; 1969 Dec 29; 52(6):444-50. PubMed ID: 4900766
    [No Abstract] [Full Text] [Related]

  • 10. Inhibition of methacholine-induced bronchoconstriction in patients with chronic obstructive pulmonary disease.
    Greenspon LW, Parrish B.
    Am Rev Respir Dis; 1988 Feb 29; 137(2):281-5. PubMed ID: 3277497
    [Abstract] [Full Text] [Related]

  • 11. BRONCHODILATORS AND CORTICOSTEROIDS IN CHRONIC BRONCHITIS AND EMPHYSEMA.
    FREEDMAN BJ.
    Br Med J; 1963 Dec 14; 2(5371):1509-12. PubMed ID: 14063078
    [No Abstract] [Full Text] [Related]

  • 12. Spirometry following glucagon and isoproterenol in chronic obstructive lung disease.
    el-Naggar M, Collins VJ.
    Crit Care Med; 1974 Dec 14; 2(2):82-5. PubMed ID: 4832285
    [No Abstract] [Full Text] [Related]

  • 13. [Spirometry].
    Schlegel J.
    Verh Dtsch Ges Inn Med; 1990 Dec 14; 96():713-9. PubMed ID: 2092511
    [No Abstract] [Full Text] [Related]

  • 14. Frequency dependence of pulmonary compliance and resistance in patients with mild and severe chronic obstructive lung disease.
    Bobbaers H, Demedts M, De Sutter P, Van de Woestijne KP.
    Bull Physiopathol Respir (Nancy); 1971 Dec 14; 7(2):425-31. PubMed ID: 5112104
    [No Abstract] [Full Text] [Related]

  • 15. BRONCHODILATING EFFECT OF BRONTINE AND ISOPRENALINE. ADDITIVE ACTION OF ISOPRENALINE INHALATION RESPECTIVE EPINEPHRINE INJECTION.
    SIMONSSON BG.
    Med Thorac; 1964 Dec 14; 21():295-302. PubMed ID: 14265982
    [No Abstract] [Full Text] [Related]

  • 16. COMPREHENSIVE THERAPY OF OBSTRUCTIVE PULMONARY DISEASE.
    LEVY D.
    Isr Med J; 1964 Dec 14; 23():97-105. PubMed ID: 14197008
    [No Abstract] [Full Text] [Related]

  • 17. Relationship between R t and FEV 1.0 before and after inhalation of isoproterenol in patients with chronic obstructive syndrome.
    Stadeler HJ, Ferlinz R, Del Valle-Monge J.
    Bull Physiopathol Respir (Nancy); 1971 Dec 14; 7(3):555-9. PubMed ID: 5119275
    [No Abstract] [Full Text] [Related]

  • 18. Alterations in airway dynamics following inhalation of ultrasonic mist.
    Malik SK, Jenkins DE.
    Chest; 1972 Dec 14; 62(6):660-4. PubMed ID: 4635412
    [No Abstract] [Full Text] [Related]

  • 19. Bronchodilator therapy: comparison of acute response to three methods of administration.
    Chester EH, Racz I, Barlow PB, Baum GL.
    Chest; 1972 Oct 14; 62(4):394-9. PubMed ID: 4562180
    [No Abstract] [Full Text] [Related]

  • 20. TREATMENT AND TREATMENT METHODS IN THE CHRONIC BRONCHITIS PULMONARY EMPHYSEMA SYNDROME.
    HALE FC, COHEN AA.
    Tuberculol Thorac Dis; 1964 Dec 14; 22():38-43. PubMed ID: 14236471
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.